CEO of UL Solutions Inc. Sells Nearly 12,000 Shares in Patterned 10b5‑1 Trades, Raising Investor Curiosity

Insider Selling on the Rise: Scanlon’s 11‑February Sale Adds to a Pattern of Trading

On November 2, 2026, UL Solutions Inc.’s President and CEO, Jennifer F. Scanlon, sold 9,800 shares of Class A common stock at an average price of $74.81 under a Rule 10b5‑1 plan adopted in December 2025. A second tranche of 2,700 shares followed at $75.83. The sale reduced her holdings to roughly 114,000 shares, or about 0.7 % of the outstanding equity. Although the price moved only 0.01 % down from the closing price of $80.40, the timing and volume raise questions about the board’s confidence in the company’s near‑term trajectory.

What Does This Mean for Investors? Scanlon’s sale is the latest in a flurry of insider activity that began in early July and has continued through October. The pattern is characterized by relatively large, orderly divestitures executed at market‑congruent prices rather than frantic panic trades. For shareholders, the repeated 10b5‑1 transactions signal that the CEO is using a pre‑established plan to manage liquidity needs or diversify her personal portfolio without signaling negative sentiment. However, the cumulative effect of these sales—together with the modest dip in the stock’s year‑to‑date performance (–6.9 %)—may prompt cautious investors to reassess whether the company’s momentum is sustainable. The current 52‑week high of $107.54 and a strong Q3 earnings report, which highlighted a 27 % EBITDA margin outlook, suggest that UL Solutions is still on a growth path, but the CEO’s selling could be interpreted as a hedge against volatility or a sign of confidence in future liquidity.

Scanlon’s Trading Profile Scanlon’s historic transactions show a disciplined use of 10b5‑1 plans: she began selling in July when shares were trading near $100, then continued with regular sales at $90–$95 in August, and moved into the $70 range in September and October. She has also accumulated Restricted Stock Units in late September and early October, balancing divestitures with new equity awards. The most recent sale at $74.81 follows a price trend that has been trending downward from the $80 peak of early November. Compared to peers in the industrials sector, Scanlon’s turnover is moderate; her holdings after the November sale remain well above the 10 % threshold that would trigger regulatory scrutiny. The pattern suggests that her 10b5‑1 plan is designed to meet liquidity needs over a multi‑year horizon rather than to signal imminent adverse developments.

Strategic Context and Outlook UL Solutions’ Q3 results underscored continued organic growth, a record EBITDA margin, and a sizable acquisition of Eurofins Scientific’s electrical and electronics unit. These moves align with the CEO’s stated focus on portfolio optimisation. The insider sales, while sizable, do not eclipse the company’s cash generation or strategic initiatives. For investors, the key take‑away is that insider activity is being managed within the bounds of regulatory safeguards and does not necessarily forecast a decline. Monitoring subsequent trades—especially any large sales or purchases in the next filing cycle—will help gauge whether the CEO’s trading rhythm signals a shift in her view of UL Solutions’ long‑term prospects.